Yuji Mano

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

ACS omega

European journal of mass spectrometry (Chichester, England)

Journal of separation science

Molecular cancer therapeutics

Eisai Co., Ltd.

The University of Tokyo (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eisai Co., Ltd.

Japan

Senior Director :: Drug Metabolism and Pharmackinetics

Astellas Pharma Inc.

Japan

Senior Researcher :: Drug Metabolism and Pharmacokinetics

Education History

The University of Tokyo

Japan

MSC :: Graduate School of Pharmaceutical Sciences

The University of Tokyo

Japan

BSC :: Pharmaceutical Sciences

Publications

Kiyomi Kikuchi, Yoko Ida, Tomohiro Yamada, Yuji Mano
Development of the Complement C5 Assay by LC-MS/MS in Monkey Serum and Comparison with Enzyme-Linked Immunosorbent Assay. ACS omega 9 (6) (2024)
Kiyomi Kikuchi, Yoko Ida, Tomohiro Yamada, Yuji Mano
Development of the Complement C5 Assay by LC-MS/MS in Monkey Serum and Comparison with Enzyme-Linked Immunosorbent Assay. ACS omega 9 (6) (2024)
Yuki Niwa, Keito Adachi, Kimiyo Tabata, Ryoga Ishida, Koichiro Hotta, Tomomi Ishida, Yuji Mano, Yoichi Ozawa, Yukinori Minoshima, Yasuhiro Funahashi, Taro Semba
Liposome-encapsulated eribulin shows enhanced antitumor activity over eribulin for combination therapy with anti-PD-1 antibody. Molecular cancer therapeutics (2023)
Takuya Sano, Takuho Ishii, Koichiro Hotta, Yuji Mano
A Simple UPLC-MS/MS Assay of Rifampin in a Small Volume of Human Plasma. ACS omega 8 (39) (2023)
Takuho Ishii, Nana Nojiri, Yuji Mano
A simple UPLC-MS/MS assay with a core-shell column for the determination of exemestane in human plasma for clinical application. European journal of mass spectrometry (Chichester, England) 28 (3-4) (2022)
Yuji Mano
A separate assay of released and liposomal encapsulated eribulin in dog plasma by liquid chromatography with tandem mass spectrometry for its application to a pharmacokinetic study. Journal of separation science 45 (10) (2022)
Yuji Mano, Hitoshi Mizuo
Minimal impact of hepatic and renal impairment on plasma protein binding of lenvatinib, and identification of its major plasma binding protein. Biopharmaceutics & drug disposition 40 (8) (2020)
Kenji Kita, Kenichi Noritake, Yuji Mano
Application of a Volumetric Absorptive Microsampling Device to a Pharmacokinetic Study of Tacrolimus in Rats: Comparison with Wet Blood and Plasma. European journal of drug metabolism and pharmacokinetics 44 (1) (2019)
Muneo Aoyama, Yuji Mano
Application of an electrochemiluminescence assay for quantification of E6011, an antifractalkine monoclonal antibody, to pharmacokinetic studies in monkeys and humans. Journal of clinical laboratory analysis 33 (1) (2018)

Yuji Mano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuji Mano